Clinigen Group (CLIN)

Sector:

Food Pharmacy Retail

Index:

FTSE AIM 50

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,009.30p
   
  • Change Today:
      14.30p
  • 52 Week High: 1,177.00
  • 52 Week Low: 837.00
  • Currency: UK Pounds
  • Shares Issued: 122.29m
  • Volume: 24,909
  • Market Cap: 1,234.23m

Clinigen Group Overview

Clinigen Group is in the food pharmacy retail sector and is currently trading at 1,009.30p per share. In the last year Clinigen Group's share price has ranged from 837.00p to 1,177.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.5% 0.5%
Div Cover 8.4 8.3
Op Mrgn 14.8% 19.5%
ROCE n/a  
Latest F'cast
P/E 23.8 22.1
PEG 0.9 2.8
Pr/Revenue 4.0 3.4
Pr/Book 4.9  
Latest F'cast
Revenue -11.1% 18.1%
PBT -11.3% 393.1%
EPS 25.1% 7.8%
DPS 25.0% 8.1%

Clinigen Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-13 122.58 14.51 22.18p 13.5 0.2 +66% 2.60p 0.9%
30-Jun-14 126.64 21.24 24.50p 15.4 1.5 +10% 3.10p 0.8%
30-Jun-15 184.40 8.30 28.00p 22.3 1.6 +14% 3.40p 0.5%
30-Jun-16 339.90 15.90 33.40p 18.1 1.0 +19% 4.00p 0.7%
30-Jun-17 302.30 14.10 41.80p 20.6 0.8 +25% 5.00p 0.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Clinigen Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 356.88 69.53 45.08p 22.1 2.8 +8% 5.40p 0.5%
30-Jun-19 416.48 86.18 55.01p 18.1 0.8 +22% 6.30p 0.6%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Clinigen Group Company Announcements

Year end trading update 17-Jul-2018 07:00 RNS
Holding(s) in Company 03-Jul-2018 09:25 RNS
Holding(s) in Company 05-Mar-2018 17:53 RNS

Latest Clinigen Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Clinigen Group Market Data

Currency UK Pounds
Share Price 1,009.30p
Change Today 14.30p
% Change 1.44 %
52 Week High 1,177.00
52 Week Low 837.00
Volume 24,909
Shares Issued 122.29m
Market Cap 1,234.23m

Clinigen Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average
Price Trend
38.44% above the market average38.44% above the market average38.44% above the market average38.44% above the market average38.44% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income
90.51% below the market average90.51% below the market average90.51% below the market average90.51% below the market average90.51% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
36.44% above the market average36.44% above the market average36.44% above the market average36.44% above the market average36.44% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Clinigen Group Dividends

  Latest Previous
  Interim Final
Ex-Div 22-Mar-18 09-Nov-17
Paid 12-Apr-18 01-Dec-17
Amount 1.76p 3.40p

Trades for 17-Jul-2018

Time Volume / Share Price
08:36 200 @ 1,009.30p
08:36 18 @ 1,009.48p
08:28 33 @ 1,009.00p
08:27 100 @ 1,009.60p
08:18 141 @ 1,012.00p

Clinigen Group Key Personnel

CEO Shaun Edward Chilton
CFO Martin Abell

Top of Page